Kalaris Therapeutics, Inc 10-K for FY2025
Kalaris Therapeutics, Inc. (KLRS)
10-K
2026-03-17
For: 2025-12-31
View Original
Added on
April 08, 2026
About this 10-K
Kalaris Therapeutics, Inc filed this 10-K on March 17, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $43.44M
- compared with a net loss of $69.17M a year earlier
- Diluted EPS
- -$2.85
- compared with -$51.77 a year earlier